HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease.
Saved in:
| Title: | HLA-DRB3/4/5-based susceptibility profiles in nivolumab-induced type 1 diabetes and interstitial lung disease. |
|---|---|
| Authors: | Nishikido S; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Mishima H; Department of Human Genetics and Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Yoshiura KI; Department of Human Genetics and Leading Medical Research Core Unit, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Sakamoto N; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Ishimoto H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.; Department of Insured Medical Care Management, Nagasaki University Hospital, Nagasaki, Japan., Morimoto S; Clinical Research Center, Nagasaki University Hospital, Nagasaki, Japan., Horie I; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan., Akazawa S; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan.; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Haraguchi A; Department of Endocrinology and Metabolism, Nagasaki University Hospital, Nagasaki, Japan., Tsujiguchi H; Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Hara A; Department of Hygiene and Public Health, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan., Tajima A; Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive Medical Sciences, Kanazawa University, Kanazawa, Japan.; Environmental Stress Research Center (eSRC), Kanazawa University, Kanazawa, Japan., Hosomichi K; Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan., Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Kawakami A; Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan., Abiru N; Division of Advanced Preventive Medical Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. |
| Source: | Frontiers in immunology [Front Immunol] 2026 Jun 02; Vol. 17, pp. 1840622. Date of Electronic Publication: 2026 Jun 02 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2026.1840622 |
